|
Leveraging comparative proteomics to improve human disease models |
1 F31 GM143881-01 |
COX, RACHAEL M |
NIGMS |
2021 |
|
Genetic Dissection of a VIP Link between Immune Dysfunction and Neurodevelopmental Disorders Characterized by Social Deficits |
1 P20 GM134974-01A1 |
LU, XIAOHONG |
NIGMS |
2021 |
|
Effects of Prenatal Alcohol Exposure on Synaptic Plasticity and Auditory Processing |
1 P20 GM139762-01 |
RAGUNATHAN, PADMASHRI |
NIGMS |
2021 |
|
Protocadherin control of cell proliferation and differentiation |
1 R01 GM141280-01 |
JONTES, JAMES DAVID |
NIGMS |
2021 |
|
Mechanisms of elesclomol-mediated copper delivery to cuproenzymes in cells |
1 R01 GM143630-01 |
GOHIL, VISHAL MAHENDRASINGH |
NIGMS |
2021 |
|
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases |
1 R01 GM146257-01 |
LU, QUN |
NIGMS |
2021 |
|
SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses |
1 R35 GM139587-01 |
AFONIN, KIRILL A |
NIGMS |
2021 |
|
Novel regulators of Slo2 potassium channels |
1 R35 GM139620-01 |
CHEN, BOJUN |
NIGMS |
2021 |
|
Chemical Approaches for Exploring Protein Prenylation in Living Cells |
1 R35 GM141853-01 |
DISTEFANO, MARK D |
NIGMS |
2021 |
|
Biophysical determination of the underlying cause of α-Syn oligomer toxicity |
1 R35 GM142869-01 |
KUROUSKI, DMITRY |
NIGMS |
2021 |